
Roy R. Teller
Examiner (ID: 12058, Phone: (571)272-0971 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1675, 1653 |
| Total Applications | 671 |
| Issued Applications | 374 |
| Pending Applications | 45 |
| Abandoned Applications | 251 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7217605
[patent_doc_number] => 20050054770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Helicomimetics and stabilized lxxll peptidomimetics'
[patent_app_type] => utility
[patent_app_number] => 10/471120
[patent_app_country] => US
[patent_app_date] => 2002-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3576
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054770.pdf
[firstpage_image] =>[orig_patent_app_number] => 10471120
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/471120 | Helicomimetics and stabilized lxxll peptidomimetics | Mar 10, 2002 | Abandoned |
Array
(
[id] => 6308037
[patent_doc_number] => 20020094991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-18
[patent_title] => 'Methods and compositions for treating microtubule-mediated viral infections and lesions'
[patent_app_type] => new
[patent_app_number] => 10/091709
[patent_app_country] => US
[patent_app_date] => 2002-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7584
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20020094991.pdf
[firstpage_image] =>[orig_patent_app_number] => 10091709
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/091709 | Methods and compositions for treating microtubule-mediated viral infections and lesions | Mar 4, 2002 | Abandoned |
Array
(
[id] => 6861624
[patent_doc_number] => 20030092632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Sulfated CCR5 peptides for HIV-1 infection'
[patent_app_type] => new
[patent_app_number] => 10/086814
[patent_app_country] => US
[patent_app_date] => 2002-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14108
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092632.pdf
[firstpage_image] =>[orig_patent_app_number] => 10086814
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/086814 | Sulfated CCR5 peptides for HIV-1 infection | Feb 27, 2002 | Abandoned |
Array
(
[id] => 585706
[patent_doc_number] => 07442683
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-28
[patent_title] => 'Cyclic peptide'
[patent_app_type] => utility
[patent_app_number] => 10/470918
[patent_app_country] => US
[patent_app_date] => 2002-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7691
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/442/07442683.pdf
[firstpage_image] =>[orig_patent_app_number] => 10470918
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/470918 | Cyclic peptide | Feb 13, 2002 | Issued |
| 09/890721 | Regulation of anaesthesia | Jan 31, 2002 | Abandoned |
Array
(
[id] => 6814080
[patent_doc_number] => 20030073630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Long lasting growth hormone releasing factor derivatives'
[patent_app_type] => new
[patent_app_number] => 10/203809
[patent_app_country] => US
[patent_app_date] => 2002-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14422
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073630.pdf
[firstpage_image] =>[orig_patent_app_number] => 10203809
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/203809 | Long lasting growth hormone releasing factor derivatives | Jan 31, 2002 | Issued |
Array
(
[id] => 5845282
[patent_doc_number] => 20020132777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients'
[patent_app_type] => new
[patent_app_number] => 10/050903
[patent_app_country] => US
[patent_app_date] => 2002-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3575
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132777.pdf
[firstpage_image] =>[orig_patent_app_number] => 10050903
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/050903 | COMPOSITIONS AND METHODS FOR ENHANCED PHARMACOLOGICAL ACTIVITY THROUGH ORAL AND PARENTERAL ADMINISTRATION OF COMPOSITIONS COMPRISING POLYPEPTIDE DRUG SUBSTANCES AND OTHER POORLY ABSORBED ACTIVE INGREDIENTS | Jan 15, 2002 | Issued |
Array
(
[id] => 6856666
[patent_doc_number] => 20030130167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Binding protein as biosensors'
[patent_app_type] => new
[patent_app_number] => 10/039799
[patent_app_country] => US
[patent_app_date] => 2002-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7198
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20030130167.pdf
[firstpage_image] =>[orig_patent_app_number] => 10039799
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/039799 | Binding protein as biosensors | Jan 3, 2002 | Issued |
Array
(
[id] => 996464
[patent_doc_number] => 06913903
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-05
[patent_title] => 'Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same'
[patent_app_type] => utility
[patent_app_number] => 10/036744
[patent_app_country] => US
[patent_app_date] => 2001-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 39130
[patent_no_of_claims] => 115
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/913/06913903.pdf
[firstpage_image] =>[orig_patent_app_number] => 10036744
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/036744 | Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same | Dec 20, 2001 | Issued |
Array
(
[id] => 1043754
[patent_doc_number] => 06867187
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-15
[patent_title] => 'Composition and method for modulating somatolactogenic function'
[patent_app_type] => utility
[patent_app_number] => 10/029079
[patent_app_country] => US
[patent_app_date] => 2001-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5036
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/867/06867187.pdf
[firstpage_image] =>[orig_patent_app_number] => 10029079
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/029079 | Composition and method for modulating somatolactogenic function | Dec 20, 2001 | Issued |
Array
(
[id] => 1104550
[patent_doc_number] => 06812003
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-02
[patent_title] => 'Compounds and methods for modulating cell-adhesion mediated drug resistance'
[patent_app_type] => B2
[patent_app_number] => 10/024017
[patent_app_country] => US
[patent_app_date] => 2001-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 16844
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/812/06812003.pdf
[firstpage_image] =>[orig_patent_app_number] => 10024017
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/024017 | Compounds and methods for modulating cell-adhesion mediated drug resistance | Dec 20, 2001 | Issued |
Array
(
[id] => 1059754
[patent_doc_number] => 06852844
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-02-08
[patent_title] => 'Human protocadherin proteins and polynucleotides encoding the same'
[patent_app_type] => utility
[patent_app_number] => 10/025225
[patent_app_country] => US
[patent_app_date] => 2001-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9126
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/852/06852844.pdf
[firstpage_image] =>[orig_patent_app_number] => 10025225
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/025225 | Human protocadherin proteins and polynucleotides encoding the same | Dec 18, 2001 | Issued |
| 10/018377 | Insulin crystals for pulmonary administration | Dec 17, 2001 | Abandoned |
Array
(
[id] => 766013
[patent_doc_number] => 07008782
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-07
[patent_title] => 'Bardet-Biedl susceptibility gene and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/025187
[patent_app_country] => US
[patent_app_date] => 2001-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37512
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/008/07008782.pdf
[firstpage_image] =>[orig_patent_app_number] => 10025187
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/025187 | Bardet-Biedl susceptibility gene and uses thereof | Dec 17, 2001 | Issued |
Array
(
[id] => 6761872
[patent_doc_number] => 20030125234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Alteration of protein stability'
[patent_app_type] => new
[patent_app_number] => 10/014758
[patent_app_country] => US
[patent_app_date] => 2001-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7657
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20030125234.pdf
[firstpage_image] =>[orig_patent_app_number] => 10014758
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/014758 | Alteration of protein stability | Dec 10, 2001 | Abandoned |
Array
(
[id] => 6697259
[patent_doc_number] => 20030109453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Compound and method for the treatment of sinusitis'
[patent_app_type] => new
[patent_app_number] => 10/015055
[patent_app_country] => US
[patent_app_date] => 2001-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 13144
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0109/20030109453.pdf
[firstpage_image] =>[orig_patent_app_number] => 10015055
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/015055 | System and method for support legacy operating system booting in a legacy-free system | Dec 9, 2001 | Issued |
Array
(
[id] => 6082204
[patent_doc_number] => 20020082199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Insoluble insulin compositions'
[patent_app_type] => new
[patent_app_number] => 10/010038
[patent_app_country] => US
[patent_app_date] => 2001-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 31141
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20020082199.pdf
[firstpage_image] =>[orig_patent_app_number] => 10010038
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/010038 | Insoluble insulin compositions | Dec 5, 2001 | Abandoned |
Array
(
[id] => 996604
[patent_doc_number] => 06914044
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-05
[patent_title] => 'Compounds and methods for modulating cell adhesion'
[patent_app_type] => utility
[patent_app_number] => 10/006982
[patent_app_country] => US
[patent_app_date] => 2001-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 45
[patent_no_of_words] => 22242
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/914/06914044.pdf
[firstpage_image] =>[orig_patent_app_number] => 10006982
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/006982 | Compounds and methods for modulating cell adhesion | Dec 3, 2001 | Issued |
Array
(
[id] => 1050225
[patent_doc_number] => 06861504
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-01
[patent_title] => 'Compounds and methods for the modulation of CD154'
[patent_app_type] => utility
[patent_app_number] => 10/002585
[patent_app_country] => US
[patent_app_date] => 2001-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17133
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/861/06861504.pdf
[firstpage_image] =>[orig_patent_app_number] => 10002585
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/002585 | Compounds and methods for the modulation of CD154 | Nov 29, 2001 | Issued |
Array
(
[id] => 1040635
[patent_doc_number] => 06869933
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-22
[patent_title] => 'HIV-specific CTL inducing peptides and medicaments for preventing or treating AIDS comprising the peptides'
[patent_app_type] => utility
[patent_app_number] => 09/994617
[patent_app_country] => US
[patent_app_date] => 2001-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 6118
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/869/06869933.pdf
[firstpage_image] =>[orig_patent_app_number] => 09994617
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/994617 | HIV-specific CTL inducing peptides and medicaments for preventing or treating AIDS comprising the peptides | Nov 27, 2001 | Issued |